logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Saturday, June 7, 2025 · 819,905,342 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Novo Nordisk News Monitoring

  • Published on Jun 4, 2025

    Five things for pharma marketers to know: Wednesday, June 4, 2025  

    At ASCO, cell therapies for deadly forms of brain cancer make early strides. Early efforts to use cell therapies for aggressive brain cancers are showing promise in a few patients, according to new data released at ASCO. (Endpoints News)  The Food and Drug …

    Source: Medical Marketing and Media - Pending
  • Published on Jun 3, 2025

    LLY Stock Too Cheap At $750?

    LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. ... More Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Getty Images)Peter Dazeley Question: Why would you pay 81 …

    Source: Forbes - Neutral
  • Published on Jun 4, 2025

    Should you buy, hold or fold Monks Investment Trust

    Experts discuss if Scottish Mortgage’s balanced cousin deserves investors’ cash. Investors should not give up on the Monks Investment Trust despite a wobbly past half decade, according to market commentators, although there is a split on whether now is a …

    Source: Trustnet - Neutral
  • Published on Jun 4, 2025

    Pharma Tuck-In Deals Grow After a Mediocre First Quarter for Small Biotechs

    And just like that, pharma is acquiring again. After a mostly dull first quarter, deals are heating up as we head into the final month of the half. Sanofi has earned the badge as the biggest buyer, putting up $9.5 billion to acquire rare disease specialist …

    Source: BioSpace - Pending
  • Published on Jun 4, 2025

    ‘After taking weight-loss drugs, my life fell apart’

    For Charlotte Lloyd*, the nightmare began last autumn. The 37-year-old social media manager from London had gained weight while undergoing fertility treatment and her BMI had reached a level that qualified her for the prescription weight-loss medication …

    Source: The Times - Center-right
  • Published on Jun 4, 2025

    GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health

    Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity. At the heart of this shift is the explosive rise of GLP-1 receptor …

    Source: National Law Review - Neutral
  • Published on Jun 3, 2025

    CNBC Daily Open: Elon Musk's companies report positive developments amid his return to work

    Elon Musk laughs during a press event with US President Donald Trump in the Oval Office of the White House in Washington, DC, on May 30, 2025. Allison Robbert | AFP | Getty Images In his first week away from the U.S. government's so-called Department …

    Source: CNBC - Neutral
  • Published on Jun 3, 2025

    Cycling the talk: Steering leadership towards sustainability

    Purposeful change is not accomplished through grand announcements, but instead through the small intentional choices we make every day. We at Novo Nordisk Global Business Services, understand this well and hence started our journey of change and impact …

    Source: The Week - Center-left
  • Published on Jun 3, 2025

    Ozempic vs. Zepbound: Which Is Better For Weight Loss?

    A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 weeks, people who took tirzepatide lost an average of 50 pounds. Here's what the new study can tell us. The term “Ozempic" …

    Source: Women’s Health - Neutral
  • Published on Jun 3, 2025

    Will European Stocks Eat The U.S. For Breakfast?

    Tuesday, June 3, 2025 1:42 PM EDT Image Source: Pexels Europe hasn’t had a look-in for a long time. Sure—love the history, great cities, food (in the south, anyway), skiing, and so on. Holiday, fine: equity markets, no thank you. That sentiment, however, …

    Source: myMotherLode - California - Pending
  • Published on Jun 3, 2025

    Other news to note for June 3, 2025

    Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Adalvo, Amyotep Biotech, Aymid, Biolinerx, Drug Farm, Formosa, Galmed, Hansoh, Novo Nordisk, Regeneron, Sumitomo. BioWorld Asia Briefs …

    Source: BioWorld - Pending
  • Published on Jun 3, 2025

    Numbers Cruncher Intuit Joins Elite Big Cap 20. Which Other Stocks Just Came On – And Off – IBD's Top Stock Screens?

    Hims stock shot higher and then tumbled Tuesday after the telehealth platform announced the pending acquisition of ZAVA, a European digital health platform. The move will expand Hims & Hers Health's (HIMS) presence in the U.K. and officially launch …

    Source: Investor's Business Daily - Neutral
  • Published on Jun 3, 2025

    Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

    American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the …

    Source: Global News - Neutral
  • Published on Jun 2, 2025

    Employers Still Reluctant To Cover Obesity Meds, But Lower Costs May Change This

    In this photo illustration, the injectable weight-loss medication Wegovy is shown. (Photo ... More Illustration by Scott Olson/Getty Images)Getty Images A new survey report from the International Foundation of Employee Benefit Plans shows continued …

    Source: Forbes - Neutral
  • Published on Jun 3, 2025

    Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge

    ReShape Lifesciences RSLS stock is trending up on Tuesday. Here’s what investors need to know. The premier physician-led weight loss and metabolic health solutions company’s Quality Management System (QMS) and entire commercial portfolio of medical devices …

    Source: Benzinga - Neutral
  • Published on Jun 3, 2025

    Wegovy use spikes among teens as doctors grapple with obesity crisis

    Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our …

    Source: The Independent - Center-left
  • Published on Jun 3, 2025

    Meet UBC's 15 New Spin-Off Companies in 2024 / 2025

    Vancouver, BC, June 3, 2025--(T-Net)--The Inventions and Licensing team at Innovation UBC announced that it has helped launch 15 new spin-offs in the 2024/2025 fiscal year, taking the total number of UBC spin-offs from 260 to 275. Each of these …

    Source: T-Net - Pending
  • Published on Jun 3, 2025

    Hims to acquire UK-based startup Zava as it expands international presence

    By Bhanvi Satija NEW YORK (Reuters) -Telehealth platform Hims & Hers said on Tuesday it will acquire London-based startup Zava for an undisclosed amount, allowing it to launch its offerings in Germany, France and Ireland and reach more international …

    Source: WIKY - Indiana - Pending
  • Published on Jun 3, 2025

    Is Europe Starting to Outshine the US in Equities?

    Europe hasn’t had a look-in for a long time. Sure—love the history, great cities, food (in the south, anyway), skiing, and so on. Holiday, fine: equity markets, no thank you. That sentiment, however, may be changing. Investors have been enthralled by US …

    Source: Investing - Neutral

25 days 07:30:54

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 819,905,342 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement